PL3538132T3 - Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit - Google Patents

Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit

Info

Publication number
PL3538132T3
PL3538132T3 PL17804828T PL17804828T PL3538132T3 PL 3538132 T3 PL3538132 T3 PL 3538132T3 PL 17804828 T PL17804828 T PL 17804828T PL 17804828 T PL17804828 T PL 17804828T PL 3538132 T3 PL3538132 T3 PL 3538132T3
Authority
PL
Poland
Prior art keywords
treatment
inflammatory bowel
bowel diseases
rectal insulin
rectal
Prior art date
Application number
PL17804828T
Other languages
English (en)
Inventor
Jørgen OLSEN
Mohammad Taha Yassin
Elm Anders Pedersen
Original Assignee
University Of Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Copenhagen filed Critical University Of Copenhagen
Publication of PL3538132T3 publication Critical patent/PL3538132T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17804828T 2016-11-14 2017-11-10 Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit PL3538132T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16198633 2016-11-14
PCT/EP2017/078900 WO2018087298A1 (en) 2016-11-14 2017-11-10 Rectal insulin for treatment of inflammatory bowel diseases
EP17804828.6A EP3538132B1 (en) 2016-11-14 2017-11-10 Rectal insulin for treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
PL3538132T3 true PL3538132T3 (pl) 2021-06-28

Family

ID=57321168

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17804828T PL3538132T3 (pl) 2016-11-14 2017-11-10 Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit

Country Status (9)

Country Link
US (1) US11400137B2 (pl)
EP (1) EP3538132B1 (pl)
CA (1) CA3041390A1 (pl)
DK (1) DK3538132T3 (pl)
EA (1) EA201991166A1 (pl)
ES (1) ES2850650T3 (pl)
PL (1) PL3538132T3 (pl)
PT (1) PT3538132T (pl)
WO (1) WO2018087298A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018294519B2 (en) 2017-06-29 2023-10-12 Ascendis Pharma A/S Auto injector with reconstitution handling support
JP7017198B2 (ja) * 2018-06-22 2022-02-08 株式会社Ａｉメディカルサービス 消化器官の内視鏡画像による疾患の診断支援方法、診断支援システム、診断支援プログラム及びこの診断支援プログラムを記憶したコンピュータ読み取り可能な記録媒体
US20220175885A1 (en) 2019-03-20 2022-06-09 Reponex Pharmaceuticals A/S Targeting biological agents to mucosal defects of the gastrointestinal tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2051574B (en) 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4406896A (en) 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
JP2921872B2 (ja) * 1989-08-28 1999-07-19 和光純薬工業株式会社 経粘膜製剤
CA2209016A1 (en) 1994-12-28 1996-07-04 Teikoku Hormone Mfg. Co., Ltd. Pharmaceutics for mucosal administration
WO1997034580A1 (en) 1996-03-21 1997-09-25 Dong Wha Pharmaceutical Industrial Co., Ltd. Suppository composition of the drug which has gastro-intestinal disturbances or undergoes the decomposition by gastric acid
AU5714601A (en) * 2000-04-19 2001-10-30 Univ Johns Hopkins Methods for prevention and treatment of gastrointestinal disorders
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
WO2002096392A1 (en) 2001-05-31 2002-12-05 Cima Labs Inc. Taste-masking of highly water-soluble drugs
US20070219131A1 (en) 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US8026211B2 (en) 2004-06-02 2011-09-27 Technion Research & Development Foundation Ltd. Methods and formulations for increasing intestinal function
WO2008132732A2 (en) 2007-04-26 2008-11-06 Oramed Pharmaceuticals Inc Methods and compositions for rectal administration of proteins
WO2008132731A2 (en) 2007-04-26 2008-11-06 Oramed Pharmaceuticals, Inc Methods and compositions for rectal administration of insulin
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법

Also Published As

Publication number Publication date
US20210038696A1 (en) 2021-02-11
ES2850650T3 (es) 2021-08-31
EP3538132B1 (en) 2020-12-30
US11400137B2 (en) 2022-08-02
DK3538132T3 (da) 2021-04-06
EP3538132A1 (en) 2019-09-18
WO2018087298A1 (en) 2018-05-17
EA201991166A1 (ru) 2019-09-30
CA3041390A1 (en) 2018-05-17
PT3538132T (pt) 2021-02-05

Similar Documents

Publication Publication Date Title
IL279020B1 (en) Use of chloroquine and calamizole compounds to treat inflammatory and cancerous conditions
ZA201807084B (en) Methods of treatment of cholestatic diseases
IL253118A0 (en) Methods for treating inflammatory diseases
PT3169328T (pt) Derivados de quinolina para o tratamento de doenças inflamatórias
HK1252037A1 (zh) 治療炎性疾病的方法
FI3865484T3 (fi) Pde9:n estäjä, jossa on imidatsopyratsinonirunko, perifeeristen sairauksien hoitoon
HRP20181914T1 (hr) Liječenje intrahepatičnih kolestatskih bolesti
HK1258994A1 (zh) 用於疾病治療的方法
HK1232220A1 (zh) 用於治療心血管疾病的 -苄基異喹啉衍生物
GB201412578D0 (en) Treatment of neurological diseases
PT3538132T (pt) Insulina retal para tratamento de doenças inflamatórias intestinais
GB201515244D0 (en) Treatment of inflammatory disease or condition
HUP1500192A2 (hu) Mannooligoszaharidok alkalmazása humán gyulladásos bélbetegségek kezelésénél
GB201517565D0 (en) Treatment of genetic diseases
GB201514909D0 (en) Treatment of autoimmune diseases
GB201414023D0 (en) Treatment of autoimmune diseases
TH1501006822A (th) การใช้ไทอะโซโล ไพริมิดิโนนสำหรับการรักษาโรคลำไส้อักเสบ